Status:
COMPLETED
Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
Doris Duke Charitable Foundation
Conditions:
HIV Infections
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
The investigators will enroll a cohort of HIV-infected pregnant women accessing PMTCT services, to better understand the incremental benefits (e.g. reduction in HIV transmission, improvements in HIV-f...
Eligibility Criteria
Inclusion
- HIV infected
- Pregnant women
- Ability to provide informed consent.
- Meets eligibility criteria for HAART initiation
Exclusion
- Unwillingness to provide informed consent
- Below the age of legal consent
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
284 Patients enrolled
Trial Details
Trial ID
NCT00753324
Start Date
May 1 2009
End Date
January 1 2012
Last Update
March 29 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CIDRZ
Lusaka, Lusaka Province, Zambia, 34681